Alexander R. McCampbell, Ph.D.

Institution:
University of Pennsylvania, Philadelphia, PA, United States
Google:
"Alexander McCampbell"
Mean distance: 18.31 (cluster 11)
 
SNBCP

Parents

Sign in to add mentor
Kenneth H. Fischbeck grad student 2001 Penn
 (Transcriptional co -activator dysfunction in polyglutamine disease.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cook CN, Wu Y, Odeh HM, et al. (2020) poly(GR) aggregation induces TDP-43 proteinopathy. Science Translational Medicine. 12
Zhang YJ, Guo L, Gonzales PK, et al. (2019) Heterochromatin anomalies and double-stranded RNA accumulation underlie poly(PR) toxicity. Science (New York, N.Y.). 363
Sweeney P, Park H, Baumann M, et al. (2017) Protein misfolding in neurodegenerative diseases: implications and strategies. Translational Neurodegeneration. 6: 6
Periz G, Lu J, Zhang T, et al. (2015) Regulation of protein quality control by UBE4B and LSD1 through p53-mediated transcription. Plos Biology. 13: e1002114
Ma L, Seager MA, Seager M, et al. (2009) Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation. Proceedings of the National Academy of Sciences of the United States of America. 106: 15950-5
McCampbell A, Taye AA, Whitty L, et al. (2001) Histone deacetylase inhibitors reduce polyglutamine toxicity. Proceedings of the National Academy of Sciences of the United States of America. 98: 15179-84
Steffan JS, Bodai L, Pallos J, et al. (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature. 413: 739-43
McCampbell A, Fischbeck KH. (2001) Polyglutamine and CBP: fatal attraction? Nature Medicine. 7: 528-30
McCampbell A, Taylor JP, Taye AA, et al. (2000) CREB-binding protein sequestration by expanded polyglutamine. Human Molecular Genetics. 9: 2197-202
See more...